Trials / Completed
CompletedNCT01037452
Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn
A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Proof-of-Concept Trial to Assess Relief of Meal Induced Heartburn by a Combination of Lansoprazole 15 mg and Antacid Versus Lansoprazole 15 mg and Antacid (Calcium Carbonate and Magnesium Hydroxide) Alone
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the safety and efficacy of an antacid/Lansoprazole combination product for the relief of heartburn after consuming a heartburn-inducing meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg | Tablet |
| DRUG | Lansoprazole | Tablet |
| DRUG | Calcium carbonate/magnesium hydroxide | Tablet |
| DRUG | Placebo | Tablet |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-01-01
- First posted
- 2009-12-23
- Last updated
- 2011-03-28
- Results posted
- 2011-03-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01037452. Inclusion in this directory is not an endorsement.